Antara Capital’s Aurinia Pharmaceuticals AUPH Stock Holding History

Antara Capital’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-500,000	Closed	-$4.89M	–	58
2023 Q2	$4.84M	Buy	+500,000	New	+$5.19M	0.16%	31
2022 Q2	–	Sell	-188,621	Closed	-$2.33M	–	274
2022 Q1	$2.33M	Buy	+188,621	New	+$2.92M	0.07%	142
2021 Q2	–	Sell	-300,988	Closed	-$3.91M	–	194
2021 Q1	$3.91M	Buy	+300,988	New	+$4.37M	0.33%	63
2020 Q2	–	Sell	-300	Closed	-$4.8K	–	63
2020 Q1	$4K	Buy	+300	New	+$5.29K	﹤0.01%	42

Other funds holding AUPH

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Antara Capital's AUPH Position: Q3 2023 in Review

Antara Capital sold out of Aurinia Pharmaceuticals (AUPH) in Q3 2023, closing a stake of 500,000 shares — an estimated $4.89M sold.

Antara Capital first reported a position in AUPH in Q1 2020 and held it in 4 quarters. The position peaked at $4.84M in Q2 2023. 198 funds tracked by Wall St. Rank hold AUPH as of Q3 2023.

Antara Capital reported no remaining Aurinia Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
Antara Capital sold 500,000 Aurinia Pharmaceuticals shares in Q3 2023, an estimated $4.89M.
Antara Capital first reported a position in Aurinia Pharmaceuticals in Q1 2020 and held it in 4 quarters.
Antara Capital's Aurinia Pharmaceuticals position peaked at $4.84M in Q2 2023.
198 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2023.

Based on Antara Capital's 13F filing for Q3 2023, filed 14 Nov 2023.